Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.

OBJECTIVE:Metabolic syndrome (MetS) or prediabetes is a complex disorder that is defined by a clustering of cardiometabolic risk factors, including obesity, hypertriglyceridemia, reduced high-density lipoprotein (HDL) cholesterol, hypertension, and insulin resistance. Among cardiometabolic risk fact...

Full description

Bibliographic Details
Main Authors: Rashmi Supriya, Bjorn T Tam, Angus P Yu, Paul H Lee, Christopher W Lai, Kenneth K Cheng, Sonata Y Yau, Lawrence W Chan, Benjamin Y Yung, Sinead Sheridan, Parco M Siu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6095502?pdf=render
_version_ 1828475387144830976
author Rashmi Supriya
Bjorn T Tam
Angus P Yu
Paul H Lee
Christopher W Lai
Kenneth K Cheng
Sonata Y Yau
Lawrence W Chan
Benjamin Y Yung
Sinead Sheridan
Parco M Siu
author_facet Rashmi Supriya
Bjorn T Tam
Angus P Yu
Paul H Lee
Christopher W Lai
Kenneth K Cheng
Sonata Y Yau
Lawrence W Chan
Benjamin Y Yung
Sinead Sheridan
Parco M Siu
author_sort Rashmi Supriya
collection DOAJ
description OBJECTIVE:Metabolic syndrome (MetS) or prediabetes is a complex disorder that is defined by a clustering of cardiometabolic risk factors, including obesity, hypertriglyceridemia, reduced high-density lipoprotein (HDL) cholesterol, hypertension, and insulin resistance. Among cardiometabolic risk factors, central obesity plays a key role in the development of MetS through alterations in the secretion of adipokines and interacts with other MetS risk factors to unfavorably influence overall cardiometabolic risk. Obesity has grasped epidemic proportions in Asia, which has the highest number of people with diabetes in the world. But, the importance of central obesity in the clustering of all four MetS risk factors or vice versa in predicting severity of MetS has not yet been investigated in Asian population. Therefore, the present study examined the influence of central obesity on circulating levels of adipokines through its interaction with the clustering of cardiometabolic risk factors of MetS including hyperglycemia, hypertriglyceridemia, dyslipidemia and hypertension in Hong Kong Chinese adults. SUBJECTS:Blood samples from 83 Hong Kong Chinese adults, who were previously screened for MetS according to the guideline of the United States National Cholesterol Education Program Expert Panel Adult Treatment Panel III criteria were selected. Insulin and adipokines, including visfatin, chemerin, plasminogen activator inhibitor-1 (PAI-1), resistin, C-C motif chemokine ligand 2 (CCL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), tumour necrosis factor-α (TNF-α), leptin and adiponectin were assessed. RESULTS:The interacting effect of central obesity with all of the other four MetS risk factors increased the proinflammatory status of adipokines (TNF-α, leptin) and decreased the anti-inflammatory status of adipokine (adiponectin). CONCLUSION:Our results indicate that the inflammatory status of MetS may be more severe in the presence of central obesity. Adipokines, as biomarkers for pathophysiological changes, may help to improve early patient identification and to predict MetS-associated morbidity and mortality.
first_indexed 2024-12-11T06:12:57Z
format Article
id doaj.art-eecc0e69c91c45779ee56ece4fa3f21a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T06:12:57Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-eecc0e69c91c45779ee56ece4fa3f21a2022-12-22T01:18:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01138e020158510.1371/journal.pone.0201585Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.Rashmi SupriyaBjorn T TamAngus P YuPaul H LeeChristopher W LaiKenneth K ChengSonata Y YauLawrence W ChanBenjamin Y YungSinead SheridanParco M SiuOBJECTIVE:Metabolic syndrome (MetS) or prediabetes is a complex disorder that is defined by a clustering of cardiometabolic risk factors, including obesity, hypertriglyceridemia, reduced high-density lipoprotein (HDL) cholesterol, hypertension, and insulin resistance. Among cardiometabolic risk factors, central obesity plays a key role in the development of MetS through alterations in the secretion of adipokines and interacts with other MetS risk factors to unfavorably influence overall cardiometabolic risk. Obesity has grasped epidemic proportions in Asia, which has the highest number of people with diabetes in the world. But, the importance of central obesity in the clustering of all four MetS risk factors or vice versa in predicting severity of MetS has not yet been investigated in Asian population. Therefore, the present study examined the influence of central obesity on circulating levels of adipokines through its interaction with the clustering of cardiometabolic risk factors of MetS including hyperglycemia, hypertriglyceridemia, dyslipidemia and hypertension in Hong Kong Chinese adults. SUBJECTS:Blood samples from 83 Hong Kong Chinese adults, who were previously screened for MetS according to the guideline of the United States National Cholesterol Education Program Expert Panel Adult Treatment Panel III criteria were selected. Insulin and adipokines, including visfatin, chemerin, plasminogen activator inhibitor-1 (PAI-1), resistin, C-C motif chemokine ligand 2 (CCL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), tumour necrosis factor-α (TNF-α), leptin and adiponectin were assessed. RESULTS:The interacting effect of central obesity with all of the other four MetS risk factors increased the proinflammatory status of adipokines (TNF-α, leptin) and decreased the anti-inflammatory status of adipokine (adiponectin). CONCLUSION:Our results indicate that the inflammatory status of MetS may be more severe in the presence of central obesity. Adipokines, as biomarkers for pathophysiological changes, may help to improve early patient identification and to predict MetS-associated morbidity and mortality.http://europepmc.org/articles/PMC6095502?pdf=render
spellingShingle Rashmi Supriya
Bjorn T Tam
Angus P Yu
Paul H Lee
Christopher W Lai
Kenneth K Cheng
Sonata Y Yau
Lawrence W Chan
Benjamin Y Yung
Sinead Sheridan
Parco M Siu
Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.
PLoS ONE
title Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.
title_full Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.
title_fullStr Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.
title_full_unstemmed Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.
title_short Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.
title_sort adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in hong kong chinese adults
url http://europepmc.org/articles/PMC6095502?pdf=render
work_keys_str_mv AT rashmisupriya adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults
AT bjornttam adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults
AT anguspyu adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults
AT paulhlee adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults
AT christopherwlai adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults
AT kennethkcheng adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults
AT sonatayyau adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults
AT lawrencewchan adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults
AT benjaminyyung adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults
AT sineadsheridan adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults
AT parcomsiu adipokinesdemonstratetheinteractinginfluenceofcentralobesitywithothercardiometabolicriskfactorsofmetabolicsyndromeinhongkongchineseadults